About methyl 2-[5-(1,3-benzodioxol-5-yl)-3-methyl-2-oxo-3H-1,4-benzodiazepin-1-yl]acetate
methyl 2-[5-(1,3-benzodioxol-5-yl)-3-methyl-2-oxo-3H-1,4-benzodiazepin-1-yl]acetate (PubChem CID 21050729) has the molecular formula C20H18N2O5
and a molecular weight of 366.37 g/mol. Its IUPAC name is methyl 2-[5-(1,3-benzodioxol-5-yl)-3-methyl-2-oxo-3H-1,4-benzodiazepin-1-yl]acetate.
Molecular Properties
| Compound Name | methyl 2-[5-(1,3-benzodioxol-5-yl)-3-methyl-2-oxo-3H-1,4-benzodiazepin-1-yl]acetate |
| PubChem CID | 21050729 |
| Molecular Formula | C20H18N2O5 |
| Molecular Weight | 366.37 g/mol |
| Exact Mass | 366.12 |
| IUPAC Name | methyl 2-[5-(1,3-benzodioxol-5-yl)-3-methyl-2-oxo-3H-1,4-benzodiazepin-1-yl]acetate |
| SMILES | COC(=O)CN1C(=O)C(C)N=C(c2ccc3c(c2)OCO3)c2ccccc21 |
| InChI | InChI=1S/C20H18N2O5/c1-12-20(24)22(10-18(23)25-2)15-6-4-3-5-14(15)19(21-12)13-7-8-16-17(9-13)27-11-26-16/h3-9,12H,10-11H2,1-2H3 |
| InChIKey | BYJCQEJWKJNFBS-UHFFFAOYSA-N |
| XLogP | 2.16 |
| TPSA | 77.43 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 366.37 |
| LogP ≤ 5 | 2.16 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Analyze methyl 2-[5-(1,3-benzodioxol-5-yl)-3-methyl-2-oxo-3H-1,4-benzodiazepin-1-yl]acetate with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of methyl 2-[5-(1,3-benzodioxol-5-yl)-3-methyl-2-oxo-3H-1,4-benzodiazepin-1-yl]acetate?
The IUPAC name of methyl 2-[5-(1,3-benzodioxol-5-yl)-3-methyl-2-oxo-3H-1,4-benzodiazepin-1-yl]acetate (CID 21050729) is methyl 2-[5-(1,3-benzodioxol-5-yl)-3-methyl-2-oxo-3H-1,4-benzodiazepin-1-yl]acetate.
What is the SMILES notation for methyl 2-[5-(1,3-benzodioxol-5-yl)-3-methyl-2-oxo-3H-1,4-benzodiazepin-1-yl]acetate?
The canonical SMILES for methyl 2-[5-(1,3-benzodioxol-5-yl)-3-methyl-2-oxo-3H-1,4-benzodiazepin-1-yl]acetate is COC(=O)CN1C(=O)C(C)N=C(c2ccc3c(c2)OCO3)c2ccccc21.
What is the InChIKey of methyl 2-[5-(1,3-benzodioxol-5-yl)-3-methyl-2-oxo-3H-1,4-benzodiazepin-1-yl]acetate?
The InChIKey is BYJCQEJWKJNFBS-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H18N2O5/c1-12-20(24)22(10-18(23)25-2)15-6-4-3-5-14(15)19(21-12)13-7-8-16-17(9-13)27-11-26-16/h3-9,12H,10-11H2,1-2H3.
What are the key properties of methyl 2-[5-(1,3-benzodioxol-5-yl)-3-methyl-2-oxo-3H-1,4-benzodiazepin-1-yl]acetate?
methyl 2-[5-(1,3-benzodioxol-5-yl)-3-methyl-2-oxo-3H-1,4-benzodiazepin-1-yl]acetate has a molecular weight of 366.37 g/mol, XLogP of 2.16, 3 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for methyl 2-[5-(1,3-benzodioxol-5-yl)-3-methyl-2-oxo-3H-1,4-benzodiazepin-1-yl]acetate is sourced from PubChem (CID 21050729), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).